JD Health International Inc. (HKG:6618)
Hong Kong
· Delayed Price · Currency is HKD 37.55
-0.70 (-1.83%)
May 6, 2025, 9:45 AM HKT
JD Health International Market Cap
JD Health International has a market cap or net worth of 122.47 billion as of May 5, 2025. Its market cap has increased by 51.79% in one year.
Market Cap
122.47B
Enterprise Value
68.24B
Revenue
61.89B
Ranking
n/a
PE Ratio
27.23
Stock Price
37.55
Market Cap Chart
Since December 8, 2020, JD Health International's market cap has decreased from 343.98B to 122.47B, a decrease of -64.39%. That is a compound annual growth rate of -20.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 122.47B | 36.26% |
| Dec 31, 2024 | 89.88B | -27.91% |
| Dec 29, 2023 | 124.67B | -45.05% |
| Dec 30, 2022 | 226.89B | 15.58% |
| Dec 31, 2021 | 196.31B | -58.90% |
| Dec 31, 2020 | 477.66B | 38.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 213.88B |
| Hansoh Pharmaceutical Group Company | 145.08B |
| WuXi Biologics | 97.88B |
| Innovent Biologics | 90.48B |
| Alibaba Health Information Technology | 82.83B |
| Akeso | 78.81B |
| Sichuan Kelun-Biotech Biopharmaceutical | 78.13B |
| Sino Biopharmaceutical | 71.04B |